SKLB-03220

CAT: 0931-MF-0097946-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0931-MF-0097946-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
2852050-29-2
Target
Histone Methyltransferase
Related Pathways
Chromatin/Epigenetic
Purity
0.9702
Bioactivity
SKLB-03220 is an orally bioavailable covalent inhibitor targeting the histone methyltransferase EZH2, an established oncology drug target involved in epigenetic regulation. SKLB-03220 is structurally based on the clinically approved EZH2 inhibitor tazemetostat and demonstrates the ability to abolish epigenetic H3K27me3 marks, thereby altering chromatin state and transcriptional activity. SKLB-03220 represents a potent small-molecule tool for cancer epigenetics research.
Smiles
O=C(C=C)NC1=CC=C(C(=C1)C=2C=C(C(=O)NCC=3C(=O)NC(=CC3C)C)C(=C(C2)N(CC)C4CCOCC4)C)C
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
MF-0094329-01SKLB-23bb
MF-0016001-01SKLB 1028
MF-0114844-01SKLB-D18
MF-0044939-01SKLB-197
MF-0118047-01SKLB-11A
MF-0094980-01SKLB-163
MF-0017330-01SKLB 610
MF-0026961-01Compound STOCK1N-03225

Alternative Products

CatalogName
HY-177497SKLB-03220
M10442-01SKLB 610
M27829-01SKLB-163
MBS3842805-01SKLB-23bb
TRC-S555010-250MGSKLB-1028
BUP12176-01SKLB 1028
MBS5804978SKLB-197
HY-178114SKLB-0124
HY-176848-01SKLB-Y13
HY-173572-01SKLB-11A

Popular Products